Delivery Order SPE2DB22D2007-SPE2DB25FH9QD
Award Date
3/6/25
Potential Completion Date
3/27/25
Potential Value
$3.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $8,334.26, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. The award is for the delivery of 4,565,173,110 units of RITUXAN HYCELA 1,600 MG-26,800 13.4ML, a pharmaceutical product, with a contract performance period ending on August 7, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award is not associated with any set-aside program....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,718.02, is for the delivery of 1,400 mg - 23,400 11.7 ml vials of the drug Rituxan Hycela. The contract type is a Delivery Order with a Firm Fixed Price pricing structure. The contract has an ultimate completion date of March 17, 2025 and was awarded on February 24, 2025. This award is...
This federal contract award (SPE2DB20D3103|SPE2DB22FM4X7) was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 1,400 mg-23,400 11.7 ml units of the drug Rituxan Hycela. The contract has a ceiling value of $11,738.44 and was awarded on a firm fixed-price basis, with a completion date of February 23, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award, valued at $21,639.70, is for the delivery of RITUXAN HYCELA 1,600 MG-26,800 13.4ML, a specialty pharmaceutical product. The contract has an ultimate completion date of February 20, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $36,664.56, is for the delivery of Rituxan Hycela, a specialty medication, and does not have a set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which runs through December 2025....
This is a delivery order award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $14,627.04, is for the delivery of 4,565,483,195 units of the biopharmaceutical product Rituxan Hycela 1,400 mg-23,400 11.7 ml. This contract supports the federal government's medical supply needs, providing critical care medications to military treatment...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 1,400 mg-23,400 11.7 ml vials of the drug Rituxan Hycela, with a ceiling value of $74,092.00 and a completion date of June 7, 2023. The contract was awarded on May 16, 2023 and is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $6,535.52 firm fixed-price delivery order is for the supply of 500mg/50mL vials of the drug Rituximab, which is used to treat certain types of cancer and autoimmune disorders. The contract has an ultimate completion date of September 5, 2024 and was awarded on September 4, 2024. It is not designated as a set-aside contract....
This is a Delivery Order (DO) with a Firm Fixed Price (FFP) contract type, awarded by the Office of the Chief Operating Officer of the Department of Health and Human Services (HHS) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $91,479.99, is for the delivery of RITUXAN 500 MG Vials to support federal healthcare programs. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999...
This federal contract award, identified as SPE2DB20D3103|SPE2DB25FM5Q8, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,870.64, is a Firm Fixed Price Delivery Order for the pharmaceutical product RUXIENCE 500 MG/50 ML VIAL 50ML. The contract has an ultimate completion date of February 4, 2025. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract...